TEVOGEN INC
TVGNNASDAQ🏆 #3416 by market capUS Equity
$6.25▼ $0.18 (−2.80%)
Market closed · at close1h—
24h▼ 2.8%
7d▼ 8.0%
14d▲ 29.4%
30d▲ 24.8%
1y▼ 87.0%
🏦Market Cap
$26M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
66
Fair
Trading Snapshot
- Day Range
- $6.19 – $6.33
- 52-Week Range
- $3.64 – $55.00
- Volume
- $3.66B
- Avg Volume
- $3.80B
- Shares Outstanding
- 4.2M
- Next Earnings
- Oct 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $756,525
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-6.79
- Dividend Yield
- —
Why Investors Own TVGN
- ✓High-growth profile — revenue up +30.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 38% gross margin and 15% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$3M▲ +31.7% YoY
Gross Margin (TTM)
37.9%▲ +1.2% YoY
Operating Income (TTM)
$777,368▲ +31.7% YoY
Free Cash Flow (TTM)
$424,776▲ +31.7% YoY
About TEVOGEN INC
A company profile for TEVOGEN INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
66/100
Analyst Price Target
ⓘAverage Target
$6.59
▲ +5.5% Upside
High Target$7.92
Low Target$5.92
Based on 30 analysts
Latest News & Updates
🚀
Barron’s·2h ago
TEVOGEN INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift TVGN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
TEVOGEN INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.